Understanding timely STEMI treatment performance: A 3-year retrospective cohort study using diagnosis-to-balloon-time

Maame Yaa A B Yiadom1, Olayemi O Olubowale1, Cathy A Jenkins2

  • 1Department of Emergency Medicine Vanderbilt University Medical Center Nashville Tennessee USA.

Insights

Timeliness of ST-segment elevation myocardial infarction (STEMI) treatment varies by initial diagnosis location. Diagnosis-to-balloon time highlights care gaps, complementing door-to-balloon time for STEMI pathways.

Area of Science:

  • Cardiology
  • Emergency Medicine
  • Health Services Research

Background:

  • ST-segment elevation myocardial infarction (STEMI) treatment pathways involve multiple locations, including referring facilities, emergency medical services (EMS), and percutaneous coronary intervention (PCI) centers.
  • Door-to-balloon time (DBT) is a standard metric, but may not fully capture the timeliness of STEMI care when diagnosis occurs outside the PCI center's emergency department (ED).

Purpose of the Study:

  • To quantify differences in STEMI treatment mobilization time based on the location of the initial diagnostic electrocardiogram (ECG).
  • To identify opportunities for improving STEMI care processes by analyzing various time intervals.

Main Methods:

  • A 3-year retrospective cohort study at a single center.
  • Patients were classified by diagnostic ECG location: referring facility, EMS, or PCI center ED.
  • Door-to-balloon time (DBT) and diagnosis-to-balloon time (dBT) with its subintervals were quantified.

Main Results:

  • Median diagnosis-to-balloon times were shortest for ED-diagnosed STEMI (78 mins), followed by EMS-identified (89 mins), and longest for referred patients (140 mins).
  • Conversely, referred patients had the shortest median door-to-balloon times (38 mins), followed by EMS-identified (64 mins), and ED-diagnosed (89 mins).
  • Time differences reflect transport needs and pre-PCI center ED activation for referred and EMS-identified STEMI cases.

Conclusions:

  • Diagnosis-to-balloon time (dBT) and its subintervals are valuable complements to door-to-balloon time (DBT) for evaluating STEMI treatment.
  • Analyzing dBT highlights needs for faster STEMI identification in ED-diagnosed patients.
  • Opportunities exist for out-of-hospital catheterization lab activation for EMS-identified STEMI and streamlined pathways for referred STEMI patients.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
86
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
94
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
281
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
121